Archive for April, 2010
« Previous EntriesRisk Of Rehospitalization For MI Nearly Doubled In Patients Treated With Both PPI And Clopidogrel.
Friday, April 30th, 2010MedPage Today (4/29, Bankhead) reported that “the risk of rehospitalization for myocardial infarction (MI) almost doubled in patients treated with both a proton pump inhibitor (PPI) and clopidogrel (Plavix) after acute MI or coronary stent deployment,” according to research published in the Archives of Internal Medicine. Researchers found that “the risk of rehospitalization for MI […]
Experts Tout Benefits Of Exercise For People Taking Antidepressants.
Monday, April 26th, 2010USA Today (4/26) reports, “Most people seeking treatment for depression or anxiety face two choices: medication or psychotherapy. But there’s a third choice that is rarely prescribed, though it comes with few side effects, low costs and a list of added benefits, advocates say.” That third option is exercise. Psychologist Jasper Smits says, “It’s become […]
Candesartan reduces new-onset diabetes risk in hypertensive patients
Tuesday, April 20th, 2010Candesartan reduces the risk for new-onset diabetes in patients with hypertension, findings from the CASE-J study suggest.
The primary findings from the randomised, multicentre Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) study were recently reported and showed that Japanese patients with hypertension had similar rates of cardiovascular disease (CVD) events regardless of whether they received treatment […]
Asthma symptoms and control improving in children
Tuesday, April 20th, 2010Children with asthma now have fewer respiratory symptoms and greater control over their disease than they did a decade ago, results from a Swedish study suggest.
Previous research has shown that, despite an increase in the prevalence of childhood asthma and use of asthma medications over the past few decades, there has been no significant increase […]
Candesartan reduces new-onset diabetes risk in hypertensive patients
Wednesday, April 14th, 2010Source: MedWire News
Candesartan reduces the risk for new-onset diabetes in patients with hypertension, findings from the CASE-J study suggest.
The primary findings from the randomised, multicentre Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) study were recently reported and showed that Japanese patients with hypertension had similar rates of cardiovascular disease (CVD) events regardless of whether they […]
